跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Appebest - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Appebest
Approved
STANDARD
Appebest
Lloyd Laboratories, Inc
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ae4dc52c428b97d6
Company
Lloyd Laboratories, Inc
Type
Standard
Approval Details
Approval Id
ae4dc52c428b97d6
Drug Approval Philippines Name
Appebest
Product Name
Appebest
Registration Number
DRP-6827-08
Brand Name
Appebest
Generic Name
Multivitamins + Buclizine Hydrochloride + Iron (as Ferrous Sulfate)
Dosage Form
Capsule
Dosage Strength
Each capsule contains: Iron (as Ferrous Sulfate) 91.4 mg Buclizine Hydrochloride Niacinamide (Vitamin B3) 5 mg Thiamine Mononitrate (Vitamin B1) 1 mg Pyridoxine Hydrochloride (Vitamin B.) 5 mcg Riboflavin (Vitamin B2) 10 mg Cyanocobalamin (Vitamin B12)10 mg
Manufacturer
Lloyd Laboratories, Inc
Trader
D.B. Manix International, Inc.
Distributor
Quad-Gen Pharmaceuticals
Issuance Date
25 July 2023
Expiry Date
15 July 2028
Pharmacologic Category
Vitamins and Minerals
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ae4dc52c428b97d6
Type
Standard
Back to Philippines FDA Approvals